收藏切换
Effects and risk factors of ceftazidime/avibactam in the treatment of carbapenem-resistant Klebsiella pneumonia infection in patients after liver transplantation
收藏切换
Changping ZHANG, Xia WANG, Yanping TIAN, Wei LIU*
World Clinical Drug | 2022, 43(3) : 288 - 293
Less
收藏切换
World Clinical Drug | 2022, 43(3): 288-293
• Article •
Effects and risk factors of ceftazidime/avibactam in the treatment of carbapenem-resistant Klebsiella pneumonia infection in patients after liver transplantation
Full
Changping ZHANG, Xia WANG, Yanping TIAN, Wei LIU*
Affiliations
  • Department of Pharmacy, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
Published: 2022-03-10 doi: 10.13683/j.wph.2022.03.014
Outline
收藏切换
Objective

To investigate the effects and risk factors of ceftazidime/avibactam (CAZ/AVI) in the treatment of carbapenem-resistant Klebsiella pneumonia (CRKP) infection in patients after liver transplantation, and it can provide reference for anti-infection treatment.

Methods

All 20 cases with CRKP infection treated by CAZ/AVI after liver transplantation in Beijing Youan hospital from October 2020 to September 2021 were retrospectively analyzed infection indexes, liver and kidney function indexes were compared before and after treatment. Pathogenic bacteria, treatment plan and course, outcome and risk factors were assessed.

Results

After liver transplantation, CRKP were detected in 8 cases, mixed infection were detected in 12 cases, among which CRKP was detected in 6 donor preservation fluids. The treatment time was (10.60±7.36) d. All 4 cases were treated with single drug (CAZ/AVI) and 16 cases were treated with combination therapy. The effective rate was 75%. After treatment, the infection indexes in the effective group were those in the ineffective group. Glutaminotransferase, total bilirubin, direct bilirubin in the effective group were lower than those in the ineffective group. Continuous renal replacement therapy (CRRT) was the risk factor for the treatment failure with CAZ/AVI.

Conclusion

CAZ/AVI can be used as a candidate choice for CRKP infection after liver transplantation, and CRRT contribute to the treatment failure.

ceftazidime/avibactam  /  liver transplantation  /  carbapenem-resistant Klebsiella pneumonia
张长平, 王霞, 田艳平, 刘炜. 头孢他啶/阿维巴坦治疗肝移植术后患者碳青霉烯耐药肺炎克雷伯菌感染的效果及风险因素评估. 世界临床药物, 2022 , 43 (3) : 288 -293 . DOI: 10.13683/j.wph.2022.03.014
Changping ZHANG, Xia WANG, Yanping TIAN, Wei LIU. Effects and risk factors of ceftazidime/avibactam in the treatment of carbapenem-resistant Klebsiella pneumonia infection in patients after liver transplantation[J]. World Clinical Drug, 2022 , 43 (3) : 288 -293 . DOI: 10.13683/j.wph.2022.03.014
Year 2022 volume 43 Issue 3
14
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.03.014
  • Receive Date:2021-12-16
  • Online Date:2026-11-19
  • Published:2022-03-10
Article Data
Affiliations
History
  • Received:2021-12-16
Funding
Affiliations
    Department of Pharmacy, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.03.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT